Neurological complications in renal failure: A review

Clinical Neurology and Neurosurgery

Volumn 107, Issue 1, 2004, Pages 1-16

  Brouns, R ^a,b   De Deyn, P P ^a,b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Dialysis; Encephalopathy; Myopathy; Neuropathy; Renal failure; Renal transplantation; Uremia

Indexed keywords

ACETAZOLAMIDE; ACICLOVIR; AMINOGUANIDINE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE; CEFAZOLIN; CIMETIDINE; CONTRAST MEDIUM; DEFEROXAMINE; DIAZEPAM; ENCAINIDE; FOLIC ACID DERIVATIVE; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHOTREXATE; METRONIDAZOLE; OKT 3; PHENYTOIN; PHOSPHATE BINDING AGENT; PSEUDOEPHEDRINE; RECOMBINANT ERYTHROPOIETIN; STEROID; TACROLIMUS; THEOPHYLLINE; THIAMINE; UNINDEXED DRUG; VIGABATRIN; VITAMIN B GROUP; VITAMIN D;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BRAIN DISEASE; BRAIN HEMORRHAGE; CEREBELLUM DISEASE; CEREBROVASCULAR ACCIDENT; DEMENTIA; DIALYSIS; DIALYSIS ENCEPHALOPATHY; DRUG ACCUMULATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXCRETION; DRUG MEGADOSE; DRUG METABOLISM; DRUG PROTEIN BINDING; EXTRAPYRAMIDAL SYMPTOM; FEMORAL NEUROPATHY; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPOTENSION; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MONONEUROPATHY; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; MYOPATHY; NEOPLASM; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; REVIEW; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TOXICITY; TREMOR; ULTRAFILTRATION; UREMIA; UREMIC ENCEPHALOPATHY; WERNICKE ENCEPHALOPATHY;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; KIDNEY FAILURE; PERIPHERAL NERVOUS SYSTEM DISEASES; RENAL REPLACEMENT THERAPY;

EID: 9344263421     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2004.07.012     Document Type: Review

References (221)

1. C.A. Mahoney, and A.I. Arieff Uremic encephalopathies: clinical, biochemical, and experimental features Am J Kidney Dis 2 3 1982 324 336
2. M.J. Aminoff N.H. Raskin Neurology and general medicine 1995 Churchill Livingstone Philadelphia 303 319
3. D.J. Burn, and D. Bates Neurology and the kidney J Neurol Neurosurg Psychiatry 65 6 1998 810 821
4. P.P. De Deyn, V.K. Saxena, H. Abts, F. Borggreve, R. D'Hooge, and B. Marescau Clinical and pathophysiological aspects of neurological complications in renal failure Acta Neurol Belg 92 4 1992 191 206
5. R. Vanholder, R. De Smet, G. Glorieux, A. Argiles, U. Bourmeister, P. Brunet European Uremic Toxin Work Group Review on uremic toxins: classification, concentration, and interindividual variability Kidney Int 63 5 2003 1934 1943
6. A. Enomoto, M. Takeda, K. Taki, F. Takayama, R. Noshiro, and T. Niwa Interactions of human organic anion as well as cation transporters with indoxyl sulfate Eur J Pharmacol 466 2003 13 20
7. J. Topczewska-Bruns, D. Pawlak, E. Chabielska, A. Tankiewicz, and W. Buczko Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency Brain Res Bull 58 4 2002 423 428
8. P.P. De Deyn, R. D'Hooge, P.P. Van Bogaert, and B. Marescau Endogenous guanidino compounds as uremic neurotoxins Kidney Int Suppl 78 2001 S77 S83
9. J.C. Pan, Y.Q. Pei, L. An, L. Lai, R. D'Hooge, and De Deyn PP Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat Neurosi Lett 209 2 1996 121 124
10. R. D'Hooge, Y.Q. Pei, J. Manil, and P.P. De Deyn The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice Brain Res 598 1/2 1992 316 320
11. R. D'Hooge, Y.Q. Pei, B. Marescau, and P.P. De Deyn Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice J Neurol Sci 112 1/2 1992 96 105
12. S.C. Hung, S.H. Hung, D.C. Tarng, W.C. Yang, T.W. Chen, and T.P. Huang Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients Am J Kidney Dis 38 5 2001 941 947
13. M. Ihara, T. Ito, C. Yanagihara, and Y. Nishimura Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature Clin Neurol Neurosurg 101 2 1999 118 121
14. G. Dunea Dialysis dementia: an epidemic that came and went ASAIO J 47 3 2001 192 194
15. K. Berend, G. van der Voet, and W.H. Boer Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe Kidney Int 59 2 2001 746 753
16. T.D. McKinney, M. Basinger, E. Dawson, and M.M. Jones Serum aluminum levels in dialysis dementia Nephron 32 1 1982 53 56
17. D.N. Kerr, M.K. Ward, H.A. Ellis, W. Simpson, and I.S. Parkinson Aluminium intoxication in renal disease Ciba Found Symp 169 1992 123 135
18. J.R. Mach, W.P. Korchik, and M.W. Mahowald Dialysis dementia Clin Geriatr Med 4 4 1988 853 867
19. P. Hernandez, and C.A. Johnson Deferoxamine for aluminium toxicity in dialysis patients ANNA J 17 3 1990 224 228
20. M.L. Gross, P. Sweny, R.M. Pearson, J. Kennedy, O.N. Fernando, and J.F. Moorhead Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation J Neurol Sci 56 1 1982 23 34
21. M.L. Gross, R. Pearson, P. Sweny, O.N. Fernando, and J.F. Moorhead Rejection encephalopathy Proc Eur Dial Transplant Assoc 18 1981 461 464
22. J.D. Port, and N.J. Beauchamp Jr Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction Radiographics 18 2 1998 353 367
23. J.W. Eschbach, M.H. Abdulhadi, J.K. Browne, B.G. Delano, M.R. Downing, and J.C. Egrie Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Intern Med 111 12 1989 992 1000
24. A. Sikole, G. Spasovski, D. Zafirov, and M. Polenakovic Epoetin omega for treatment of anemia in maintenance hemodialysis patients Clin Nephrol 57 3 2002 237 245
25. N. Delanty, C. Vaughan, S. Frucht, and P. Stubgen Erythropoietin- associated hypertensive posterior leukoencephalopathy Neurology 49 3 1997 686 689
26. A.E. Raine, and S.D. Roger Effects of erythropoietin on blood pressure Am J Kidney Dis 18 4 Suppl 1 1991 76 83
27. J. Walter, J. Gal, and I. Taraba The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients Artif Organs 19 1 1995 76 80
28. P. Benna, F. Lacquaniti, G. Triolo, P. Ferrero, and B. Bergamasco Acute neurologic complications of hemodialysis. Study of 14,000 hemodialyses in 103 patients with chronic renal failure Ital J Neurol Sci 2 1 1981 53 57
29. S.M. Silver, R.H. Sterns, and M.L. Halperin Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis 28 1 1996 1 13
30. S.M. Silver, J.A. DeSimone Jr., D.A. Smith, and Sterns RH Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect" Kidney Int 42 1 1992 161 166
31. J.P. Galons, T. Trouard, A.F. Gmitro, and Y.H. Lien Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging J Clin Invest 98 3 1996 750 755
32. L.A. Pedrini, S. Zereik, and S. Rasmy Causes, kinetics and clinical implications of post-hemodialysis urea reboud Kidney Int 34 6 1988 817 824
33. C. Ichai, E. Fenouil, and D. Grimaud Osmolality and brain Ann Fr Anesth Reanim 13 1 1994 68 79
34. A.B. Rivera-Vazques, A. Noriega-Sanchez, R. Ramirez-Gonzalez, and M. Martinez-Maldonado Acute hypercalcemia in hemodialysis patients: distinction from 'dialysis dementia' Nephron 25 5 1980 243 246
35. J.E. Riggs Neurologic manifestations of fluid and electrolyte disturbances Neurol Clin 7 3 1989 509 523
36. A. Ortiz, N. Martin-Llonch, M.P. Garron, M.L. Alberola, C. Caramelo, and A. Ortiz-Gonzalez Cefazolin-induced encephalopathy in uremic patients Rev Infect Dis 13 4 1991 772 773
37. N. Arik, N. Cengiz, and A. Bilge Metronidazole-induced encephalopathy in a uremic patient: a case report Nephron 89 1 2001 108 109
38. G. Ifergane, R. Masalha, R. Zigulinski, L. Merkin, I. Wirguin, and Y.O. Herishanu Acute encephalopathy associated with vigabatrin monotherapy in patients with mild renal failure Neurology 51 1 1998 314 315
39. D.A. Muruve, and T.I. Steinman Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency Clin Nephrol 45 6 1996 406 409
40. R. Peces, M. de la Torre, and Alcazar R Acyclovir-associated encephalopathy in haemodialysis Nephrol Dial Transplant 11 4 1996 752
41. W.C. Cheung, C.Y. Lo, W.K. Lo, M. Ip, and I.K. Cheng Isoniazid-induced encephalopathy in dialysis patients Tuber Lung Dis 74 2 1993 136 139
42. A. Tartini, and M. Kesselbrenner Encainide-induced encephalopathy in a patient with chronic renal failure Am J Kidney Dis 15 2 1990 178 179
43. D.A. Sica, and T.J. Comstock Pseudoephedrine accumulation in renal failure Am J Med Sci 298 4 1989 261 263
44. R. Vanholder, N. Van Landschoot, R. De Smet, A. Schoots, and S. Ringoir Drug protein binding in chronic renal failure: evaluation of nine drugs Kidney Int 33 5 1989 996 1004
45. S.H. Chang, C.S. Lim, T.S. Low, H.T. Chon, and S.Y. Tan Cyclosporine-associated encephalopathy: a case report and literature review Transplant Proc 33 7-8 2001 3700 3701
46. P. Parvex, M. Pinsk, L.E. Bell, A.M. O'Gorman, Y.G. Patenoude, and I.R. Gupta Reversible encephalopathy associated with tacrolimus in pediatric renal transplants Pediatr Nephrol 16 7 2001 537 542
47. P.M. Paizel, H.W. Snoeck, L. van den Hauwe, K. Boven, J.L. Bosmans, and J.W. Van Goethem Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings AJNR 18 10 1997 1935 1938
48. J.D. Pirsch, J. Miller, M.H. Deierhoi, F. Vincenti, and R.S. Filo A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation FK506 Kidney Transplant Study Group Transplantation 63 7 1997 977 983
49. A.K. Scheel, S. Blaschke, V. Schettler, C. Mayer, G.A. Muller, and H.J. Bittermann Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports Transplant Proc 33 78 2001 3693 3694
50. W.O. Bechstein Neurotoxicity of calcineurin inhibitors; impact and clinical management Transplant Int 13 5 2000 313 326
51. S. Inoha, T. Inamura, A. Nakamizo, K. Ikezaki, T. Amono, and M. Fukui Magnetic resonance imaging in cases with encephalopathy secondary to immunosuppressive agents J Clin Neurosci 9 3 2002 305 307
52. M. Furukawa, S. Terae, B.C. Chu, K. Kaneko, H. Kamada, and K. Miyasaka MRI in seven cases of tacrolimus FK-506-encephalopathy: utility of FLAIR and diffusion-weighted imaging Neuroradiology 43 8 2001 615 621
53. W.S. Bartynski, Z. Zeigler, M.P. Spearman, L. Lin, R.K. Shadduck, and J. Lister Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 AJNR 22 10 2001 1901 1914
54. H. Ikesue, Y. Kataoka, R. Kawachi, S. Dohgu, H. Shuto, and R. Oishi Cyclosporine enhances alpha1-adrenoceptor-mediated nitric oxide production in C6 glioma cells Eur J Pharmacol 407 3 2000 221 226
55. K.M. Chow, A.Y. Wang, A.C. Hui, T.Y. Wong, C.C. Szeto, and P.K. Li Nonconvulsive status epilepticus in peritoneal dialysis patients Am J Kidney Dis 38 2 2001 400 405
56. I. Fukunishi, T. Kitaoka, T. Shirai, K. Kino, E. Kanematsu, and Y. Sato Psychiatric disorders among patients undergoing hemodialysis therapy Nephron 91 2 2002 344 347
57. P. Lass, J.R. Buscombe, M. Harber, A. Davenport, and A.J. Hilson Cognitive impairment in patients with renal failure is associated with multiple-infarct dementia Clin Nucl Med 24 8 1999 561 565
58. P.M. Rob, C. Niederstadt, and E. Reusche Dementia in patients undergoing long-term dialysis: aetiology, differential diagnosis, epidemiology and management CNS Drugs 15 9 2001 691 699
59. G.M. Savazzi, F. Cusmano, S. Vinci, and L. Allegri Progression of cerebal atrophy in patients on regular hemodialysis treatment: long-term follow-up with cerebral computed tomography Nephron 69 1 1995 29 33
60. G.M. Savazzi, F. Cusmano, and T. Degasperi Cerebral atrophy in patients on long-term regular hemodialysis treatment Clin Nephrol 23 2 1985 89 95
61. K. Kretzschmar, W. Nix, H. Zschiedrich, and T. Philipp Morphologic cerebral changes in patients undergoing dialysis for renal failure AJNR 4 3 1983 439 441
62. G.M. Savazzi, F. Cusmano, E. Bergamaschi, S. Vinci, L. Allegri, and G. Garini Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients Nephron 81 1 1999 17 24
63. G.M. Savazzi Pathogenesis of cerebral atrophy in uraemia. State of the art Nephron 49 2 1988 94 103
64. G.M. Savazzi, F. Cusmano, and S. Musini Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis Nephron 89 1 2001 31 36
65. L. Capron, and G. Grateau Accelerated arterial disease in renal transplant recipients Nephrol Dial Transplant 13 Suppl 4 1998 49 50
66. K. Iseki, and K. Fukiyama Clinical demographics and long-term prognosis after stroke in patients on chronic hemodialysis. The Okinawa Dialysis Study Group Nephrol Dial Transplant 15 11 2000 1808 1813
67. A.K. Cheung, M.J. Sarnak, G. Yan, J.T. Dweyer, R.J. Heyka, and M.V. Rocco Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Kidney Int 58 1 2000 353 362
68. P.P. De Deyn, R. Vanholder, and R. D'Hooge Nitric oxide in uremia: effects of several potentially toxic guanidino compounds Kidney Int Suppl 84 2003 25 28
69. P. Jungers, Z.A. Massy, T.N. Khoa, C. Fumeron, M. Labrunie, and B. Lacour Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study Nephrol Dial Transplant 12 12 1997 2597 2602
70. P. Jungers, P. Chauveau, O. Bandin, B. Chadefaux, J. Aupetit, and M. Labrunie Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients Miner Electrolyte Metab 23 3-6 1997 170 173
71. A.F. Perna, D. Ingrosso, P. Castaldo, N.G. De Santo, P. Galleti, and V. Zappia Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications Miner Electrolyte Metab 25 1/2 1999 95 99
72. T.B. Drueke, and Z.A. Massy Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia Blood Purif 20 5 2002 494 497
73. G. Segarra, P. Medina, R.M. Ballester, P. Lluch, M. Aldasoro, and J.M. Vila Effects of some guanidino compounds on human cerebral arteries Stroke 30 10 1999 2206 2210
74. A. Torremans, G. Van de Vijver, R. Vanholder, B. Marescau, R. D'Hooge, and P.P. De Deyn Effect of NaCN on currents evoked by uremic retention solutes in dissociated mouse neurons Brain Res 1008 1 2004 107 112
75. Z.A. Massy, D. Borderie, T. Nguyen-Koa, T.B. Drueke, O.G. Ekindjian, and B. Lacour Increased plasma S-nitrosothiol levels in chronic haemodialysis patients Nephrol Dial Transplant 18 8 2003 153 157
76. Z.A. Massy, C. Fumeron, D. Borderie, P. Tuppin, T. Nguyen-Khoa, and M.O. Benoit Increased plasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study J Am Soc Nephrol 15 2 2004 470 476
77. M. Peppa, J. Uribarri, W. Cai, M. Lu, and H. Vlassara Glycoxidation and inflammation in renal failure patients Am J Kidney Dis 43 4 2004 690 695
78. S. Vicca, Z.A. Massy, C. Hennequin, D. Rihane, T. Nguyen-Khoa, and T.B. Drueke New insights into the effects of the protein moiety of oxidized LDL Kidney Int Suppl 84 2003 S125 S127
79. T. Nguyen-Khoa, Z.A. Massy, J.P. De Bandt, M. Kebede, L. Salama, and G. Lambrey Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment Nephrol Dial Transplant 16 2 2001 335 340
80. J. Uribarri, M. Peppa, W. Cai, T. Goldberg, M. Lu, and S. Baliga Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients Am J Kidney Dis 42 3 2003 532 538
81. C. van Ypersele de Strihou Advanced glycation in uraemic toxicity EDTNA ERCA J 29 3 2003 148 150
82. C.L. Lin, C.C. Huang, C.C. Yu, H.Y. Yang, F.R. Chuang, and C.W. Yang Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients Am J Kidney Dis 42 3 2003 524 531
83. I.M. Graham, L.E. Daly, H.M. Refsum, K. Robinson, L.E. Brattstrom, and P.M. Ueland Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project JAMA 267 22 1997 1775 1781
84. A.F. Perna, P. Castaldo, D. Ingrosso, and N.G. De Santo Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin J Nephrol 12 4 1999 230 240
85. H. Fellah, M. Feki, M. Hsairi, H. Sanhaji, N. Kaabachi, and T. Ben Abdallah Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients Clin Chem Lab Med 41 5 2003 675 680
86. A.F. Perna, D. Ingrosso, N.G. De Santo, P. Galletti, M. Brunone, and V. Zappia Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia J Am Soc Nephrol 8 12 1997 1899 1905
87. Jungers P, Joly D, Massy Z, Chauveau P, Nguyen AT, Aupetit J, Chadefaux B. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.
88. C. Van Guldener, M.J. Janssen, J. Lambert, P.M. ter Wee, A.J. Donker, and C.D. Stehouwer Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy Perit Dial Int 18 3 1998 282 289
89. C. Van Guldener, M.J. Janssen, J. Lambert, P.M. ter Wee, C. Jakobs, and A.J. Donker No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients Nephrol Dial Transplant 13 1 1998 106 112
90. A.G. Bostom, D. Shemin, P. Bagley, Z.A. Massy, A. Zanabli, and K. Christopher Controlled comparison of l-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients Circulation 101 24 2000 2829 2832
91. Z.A. Massy Potential strategies to normalize the levels of homocysteine in chronic renal failure patients Kidney Int Suppl 84 2003 S134 S136
92. A. Van Tellingen, M.P. Grooteman, P.C. Bartels, J. Van Limbeek, C. Van Guldener, and P.M. Wee Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients Kidney Int 59 1 2001 342 347
93. F. Galli, S. Benedetti, U. Buoncristiani, M. Piroddi, C. Conte, and F. Canestrari The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels Kidney Int 64 2 2003 748 755
94. A.S. De Vriese, M. Langlois, D. Bernard, I. Geerolf, L. Stevens, and J.R. Boelaert Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients Nephrol Dial Transplant 18 12 2003 2596 2600
95. F. Locatelli, J.B. Cannata-Andia, T.B. Drueke, W.H. Horl, D. Fouque, and O. Heimburger Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia Nephrol Dial Transplant 17 5 2002 723 731
96. Z.A. Massy, and W.F. Keane Pathogenesis of atherosclerosis Semin Nephrol 16 1 1996 12 20
97. P.S. Parfrey Cardiac and cerebrovascular disease in chronic uremia Am J Kidney Dis 21 1 1993 77 80
98. P. Jungers, Z. Qualim, T. Nguyen-Koa, Z. Massy, and G. London Cardioprotection: an essential component for predialysis chronic renal failure treatment Nephrologie 24 2 2003 79 88
99. M. Agraharkar, M.A. Martinez, Y.F. Kuo, and T.S. Ahuja Hospitalisation for initiation of maintenance hemodialysis Nephron Clin Pract 97 2 2004 c54 c60
100. M.H. Chang, and K.J. Chou The role of autonomic neuropathy in the genesis of intradialytic hypotension Am J Nephrol 21 5 2001 357 361
101. C.P. Warlow, M.S. Dennis, J. van Gijn, G.J. Hankey, P.A.G. Sandercock, and J.M. Bamford A practical guide to management 2002 Blackwell Science Ltd. Oxford (pp. 255-258)
102. G.A. Knoll, J.A. Grabowski, G.F. Dervin, and K. O'Rourke A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension J Am Soc Nephrol 15 2 2004 487 492
103. H. Hoeben, A.K. Abu-Alfa, R. Mahnensmith, and M.A. Perazella Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine Am J Kidney Dis 39 1 2002 102 107
104. U.C. Brewster, M.A. Ciampi, A.K. Abu-Alfa, and M.A. Perazella Addition of sertraline to other therapies to reduce dialysis-associated hypotension Nephrology 8 6 2003 296 301
105. J.L. Abramson, C.T. Jurkovitz, V. Vaccarino, W.S. Weintraub, and W. McClellan Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study Kidney Int 64 2 2003 610 615
106. T.B. Drueke Aspects of cardiovascular burden in pre-dialysis patients Nephron 85 Suppl 1 2000 9 14
107. G. Di Minno, J. Martinez, M.L. McKean, J. De La Rosa, J.F. Burke, and S. Murphy Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis Am J Med 79 5 1985 552 559
108. M. Kawamura, S. Fijimoto, S. Hisanaga, Y. Yamamoto, and T. Eto Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis Am J Kidney Dis 31 6 1998 991 996
109. K. Iseki, K. Kinjo, Y. Kimura, A. Osawa, and K. Fukiyama Evidence for high risk of cerebral hemorrhage in chronic dialysis patients Kidney Int 44 5 1993 1086 1090
110. E.F. Wijdicks, V.E. Torres, W.I. Schievink, and S. Sterioff Cerebral hemorrhage in recipients of renal transplantation Mayo Clin Proc 74 11 1999 1111 1112
111. M.J. Janssen, and van der Meulen J The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients Neth J Med 48 5 1996 198 207
112. K. Onoyama, S. Ibayashi, F. Nanishi, S. Okuda, Y. Oh, and H. Hirakata Cerebral hemorrhage in patients on maintenance hemodialysis. CT analysis of 25 cases Eur Neurol 26 3 1987 171 175
113. K. Iseki, and K. Fukiyama Predictors of stroke in patients receiving chronic hemodialysis Kidney Int 50 5 1996 1672 1675
114. A.F. Da Silva, X. Escofet, and P.A. Rutherford Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts Cochrane Database Syst Rev 2 2003 CD002786
115. J.C. Lieske, and F.G. Toback Autosomal dominant polycystic kidney disease J Am Soc Nephrol 3 8 1993 1442 1450
116. S. Graf, A. Schischma, K.E. Eberhardt, R. Istel, B. Stiasny, and B.D. Schulze Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease Nephrol Dial Transplant 17 5 2002 819 823
117. M.M. Belz, R.L. Hughes, W.D. Kaehny, A.M. Johnson, G.M. Fick-Brosnahan, and M.P. Earnest Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease Am J Kidney Dis 38 4 2001 770 776
118. W.I. Schievink, V.E. Torres, D.O. Wiebers, and J. Huston 3rd Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney disease J Am Soc Nephrol 8 8 1997 1298 1303
119. N. Yorioka, H. Oda, T. Ogawa, Y. Taniguchi, S. Kushihata, and A. Takemasa Continuous ambulatory peritoneal dialysis is superior to hemodialysis in chronic dialysis patients with cerebral hemorrhage Nephron 67 3 1994 365 366
120. A. Leonard, and F.L. Shapiro Subdural hematoma in regularly hemodialyzed patients Ann Intern Med 82 5 1975 650 658
121. R. Inzelberg, M.Y. Neufeld, I. Reider, and P. Gari Non surgical treatment of subdural hematoma in a hemodialysis patient Clin Neurol Neurosurg 91 1 1989 85 89
122. D.P. Tietjen, J. Moore Jr., and S.F. Gouge Hemodialysis-associated acute subdural hematoma. Iterim management with peritoneal dialysis Am J Nephrol 7 6 1987 478 481
123. G. Bidwell, D. Sherrard, and M. Mathews Peritoneal dialysis: a temporizing means for hemodialysis patients with subdural hematomas Nephron 18 6 1977 352 353
124. M. Kilinc, U.S. Benli, and U. Can Osmotic myelinolysis in a normonatremic patient Acta Neurol Belg 102 2 2002 87 89
125. S. Pradhan, R. Jha, M.N. Singh, S. Gupta, R.V. Phadke, and V. Kher Central pontine myelinolysis following 'slow' correction of hyponatremia Clin Neurol Neurosurg 97 4 1995 340 343
126. C.S. Loo, T.O. Lim, K.S. Fan, Z. Murad, and A.B. Suleiman Pontine myelinolysis following correction of hyponatremia Med J Malaysia 50 2 1995 180 182
127. J. Artieda, J. Muruzabal, R. Larumbe, C. Garcia de Casasola, and J.A. Obeso Cortical mechanisms mediating asterixis Mov Disord 7 3 1992 209 216
128. E.W. Massey, M.H. Bowman, and M.P. Rozear Asterixis mimicking drop attacks in chronic renal failure Neurology 38 4 1988 663
129. E. Andermann, F. Andermann, S. Carpenter, L.S. Wolfe, R. Nelson, and G. Patry Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology Adv Neurol 43 1986 87 103
130. D. Chadwick, and A.T. French Uraemic myoclonus: an example of reticular reflex myoclonus? J Neurol Neurosurg Psychiatry 42 1 1979 52 55
131. S.C. Hung, S.H. Hung, D.C. Tarng, W.C. Yang, and T.P. Huang Chorea induced by thiamine deficiency in hemodialysis patients Am J Kidney Dis 37 2 2001 426 430
132. H.C. Wang, P. Brown, and A.J. Lees Acute movement disorders with bilateral basal ganglia lesions in uremia Mov Disord 13 6 1998 952 957
133. V. Collado-Seidel, R. Kohnen, W. Samtleben, G.F. Hillebrand, W.H. Oertel, and Trenkwalder C Clinical and biachemical findings in uremic patients with and without restless legs syndrome Am J Kidney Dis 31 2 1998 324 328
134. J.W. Winkelman, G.M. Chertow, and J.M. Lazarus Restless legs syndrome in end-stage renal disease Am J Kidney Dis 28 3 1996 372 378
135. P.G. Kerr, C. van Bakel, and JK Dawborn Assessment of the symptomatic benefit of cool dialysate Nephron 52 1989 166 169
136. T.C. Wetter Restless legs syndrome: a review for the renal care professionals EDTNA ERCA J 26 1 2001 42 46
137. M.S. Joy Clonazepam: benzodiazepine therapy for the restless legs syndrome ANNA J 24 6 1997 686 689
138. M. Ausserwinkler, and P. Schmidt Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency Schweiz Med Wochenschr 119 6 1989 184 186
139. L. Janzen, J.A. Rich, and L.M. Vercaigne An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy Ann Pharmacother 33 1 1999 86 92
140. F.J. Winkelmann, A. Stautner, W. Samtleben, and C. Trenkwalder Long-term course of restless legs syndrome in dialysis patients after kidney transplantation Mov Disord 17 5 2002 1072 1076
141. M.P. Barczyk, W.J. Lebkowski, Z. Mariak, J. Malyszko, and M. Mysliwiec Brain abscess as a rare complication in a hemodialysed patient Med Sci Monit 7 6 2001 1329 1333
142. S.K. Gupta, K.S. Manjunath-Prasad, B.S. Sharma, V.K. Khosla, V.K. Kak, and M. Minz Brain abscess in renal transplant recipients: report of three cases Surg Neurol 48 3 1997 284 287
143. K.M. Wong, W.L. Chak, Y.H. Chan, K.S. Choi, K.F. Chau, and K.C. Lee Subcutaneous nodules attributed to nocardiosis in a renal transplant recipient on tacrolimus therapy Am J Nephrol 20 2 2000 138 141
144. C. Mrowka, B. Heintz, J. Weis, L. Mayfrank, J. Reul, and H.G. Sieberth Isolated cerebral aspergilloma: long-term survival of a renal transplant recipient Clin Nephrol 47 6 1997 394 396
145. A. Bruno, and H.P. Adams Jr Neurologic problems in renal transplant recipients Neurol Clin 6 2 1988 305 325
146. T. Irie, M. Kasai, N. Abe, K. Seto, T. Naohara, and K. Kawamura Cerebellar form of progressive multifocal leukoencephalopathy in a patient with chronic renal failure Intern Med 31 2 1992 218 223
147. M.A. Reis, R.S. Costa, and A.S. Ferraz Causes of death in renal transplant recipients: a study of 102 autopsies from 1968 to 1991 J R Soc Med 88 1 1995 24 27
148. R. Vanholder, and S. Ringoir Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review J Am Soc Nephrol 3 9 1993 1541 1554
149. H.J. Kolmos Spinal epidural abscess in patients on maintenance haemodialysis (a presentation of two cases) Int Urol Nephrol 11 3 1979 249 253
150. K. Cengiz Increased incidence of neoplasia in chronic renal failure (20-year experience) Int Urol Nephrol 33 1 2002 121 126
151. J.L. Bosmans, D. Ysebaert, A.M. De Cock, E. Hauben, L. Muylle, and D. Schrijvers Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report Transplant Proc 29 1/2 1997 838
152. E. Urasaki, H. Yamada, T. Tokimura, and A. Yokota T-cell type primary spinal intramedullary lymphoma associated with human T-cell lymphotropic virus type I after renal transplant: case report Neurosurgery 38 5 1996 1036 1039
153. K. Schwechheimer, and A. Hashemian Neuropathologic findings after organ transplantation. An autopsy study Gen Diagn Pathol 141 1 1995 35 39
154. S.M. Hacker, B.P. Knight, N.M. Lunde, J. Gratiot-Deans, H. Sandler, and A.B. Leichtman A primary central nervous system T-cell lymphoma in a renal transplant patient Transplantation 53 3 1992 691 692
155. J.T. Kwan, F.E. Cotter, L.E. Pollock, P. Altmann, R.H. Lord, and M.J. Raftery EBV-genome positive monoclonal B cell cerebral lymphoma in a renal allograft recipient following OKT3 therapy Nephrol Dial Transplant 7 4 1992 360 361
156. M.A. Nalesnik The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach Transplant Infect Dis 3 2 2001 88 96
157. D. Gill, H.G. Juffs, K.A. Herzig, A.M. Brown, C.M. Hawley, and R.G. Cobcroft Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation Transplant Proc 35 1 2003 256 257
158. P. Porcu, C.F. Eisenbeis, R.P. Pelletier, E.A. Davies, R.A. Baiocchi, and S. Roychowdhury Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration Blood 100 7 2002 2341 2348
159. W.T. Miller Jr., S.G. Siegel, and K.T. Montone Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population Crit Rev Diagn Imaging 38 6 1997 569 585
160. P.V. Keogh, V. Fisher, and S.R. Flint Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 6 2002 697 701
161. I. Penn, and G. Porat Central nervous system lymphomas in organ allograft recipients Transplantation 59 2 1995 240 244
162. P. Maisonneuve, L. Agodoa, R. Gellert, J.H. Stewart, G. Buccianti, and A.B. Lowenfels Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Lancet 354 9173 1999 93 99
163. R.W. Evan, and B. Mokri Spontaneous intracranial hypotension resulting in coma Headache 42 2 2002 159 160
164. B. Mokri Spontaneous intracranial hypotension Curr Neurol Neurosci Rep 1 2 2001 109 117
165. F. Thomke, A. Bredel-Geissler, A. Mika-Gruttner, W. Muller-Forell, J. Andreas, and V. Kuhl Spontaneous intracranial hypotension syndrome. Clinical, neuroradiological and cerebrospinal fluid findings Nervenarzt 70 10 1999 909 915
166. D.K. Binder, W.P. Dillon, R.A. Fishman, and Schmidt MH ntrathecal saline infusion in the treatment of obtundation associated with spontaneous intracranial hypotension: technical case report Neurosurgery 51 3 2002 836 837
167. L. Spelle, A. Boulin, C. Tainturier, A. Visot, P. Graveleau, and L. Pierot Neuroimaging features of spontaneous intracranial hypotension Neuroradiology 43 8 2001 622 627
168. E. Ferrante, M. Riva, A. Gatti, A. Brioschi, A. Guccione, and N. Colombo Intracranial hypotension syndrome: neuroimaging in five spontaneous cases and etiopathogenetic correlations Clin Neurol Neurosurg 100 1 1998 33 39
169. J. Guy, P.K. Johnston, J.J. Corbett, A.L. Day, and J.S. Glaser Treatment of visual loss in pseudotumor cerebri associated with uremia Neurology 40 1 1990 28 32
170. D. Chang, G. Nagamoto, and W.E. Smith Benign intracranial hypertension and chronic renal failure Cleve Clin J Med 59 4 1992 419 422
171. A. Korzets, U. Gafter, S. Floru, A. Chagnac, and D. Zevin Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri Am J Kidney Dis 21 3 1993 322 324
172. S. Garcia, F. Cofan, A. Combalia, J.M. Campistol, F. Oppenheimer, and R. Ramon Compression of the ulnar nerve in Guyon's canal by uremic tumoral calcinosis Arch Orthop Trauma Surg 120 3/4 2000 228 230
173. G. Mourad, and A. Argiles Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis J Am Soc Nephrol 7 5 1996 798 804
174. J. Floege, and M. Ketteler Beta2-microglobulin-derived amyloidosis: an update Kidney Int Suppl 78 2001 S164 S171
175. Y. Hirasawa, and T. Ogura Carpal tunnel syndrome in patients on long-term haemodialysis Scand J Plast Surg Hand Surg 34 4 2000 373 381
176. T.B. Drueke Beta2-microglobulin and amyloidosis Nephrol Dial Transplant 15 Suppl 1 2000 17 24
177. I. Chary-Valckenaere, M. Kessler, D. Mainard, L. Schertz, J. Chanliau, and J. Champigneulle Amyloid and non-amyloid carpal tunnel syndrome in patients receiving chronic renal dialysis J Rheumatol 25 6 1998 1164 1170
178. F. Gejyo, H. Kimura, S. Suzuki, R. Miyazaki, H. Naiki, and Nakakuki K Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis Kidney Int Suppl 62 1997 S75 S78
179. F. Cofan, S. Garcia, S. Combalia, A. Combalia, J.M. Segur, and F. Oppenheimer Carpal tunnel syndrome secondary to uraemic tumoral calcinosis Rheumatology (Oxford) 41 6 2002 701 703
180. S. Kumar, H.L. Trivedi, and E.K. Smith Carpal tunnel syndrome: a complication of arteriovenous fistula in hemodialysis patients Can Med Assoc J 113 11-12 1975 1070 1072
181. N.D. Vaziri, C.H. Barton, G.R. Ravikumar, D.C. Martin, R. Ness, and J. Saiki Femoral neuropathy: a complication of renal transplantation Nephron 28 1 1981 30 31
182. N.D. Vaziri, J. Barnes, M. Khosrow, R. Ehrlich, and S.M. Rosen Compression neuropathy subsequent to renal transplantation Urology 7 2 1976 145 147
183. K.R. Sharma, J. Cross, F. Santiago, D.R. Ayyar, and G. Burke Incidence of acute femoral neuropathy following renal transplantation Arch Neurol 59 4 2002 541 545
184. G. Galassi, S. Ferrari, M. Cobelli, and N. Rizzuto Neuromuscular complications of kidney diseases Nephrol Dial Transplant 13 Suppl 7 1998 41 47
185. D. Dumitru, A. Amato, and M. Zwarts Electrodiagnostic Medicine 2002
186. U. Lindblom, and R. Tegner Thermal sensitivity in uremic neuropathy Acta Neurol Scand 71 4 1985 290 294
187. R. Tegner, and B. Lindholm Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy Acta Neurol Scan 71 4 1985 284 289
188. G. Yosipovitch, D. Yarnitsky, V. Mermelstein, E. Sprecher, J. Reiss, and C. Witenberg Paradoxal heat sensation in uremic polyneuropathy Muscle Nerve 18 7 1995 768 771
189. M.H. Chang, and K.J. Chou The role of autonomic neuropathy in the genesis of intradialytic hypotension Am J Nephrol 21 5 2001 357 361
190. G. Solders, A. Persson, and H. Wilczek Autonomic system dysfunction and polyneuropathy in nondiabetic uremia. A one-year follow-up study after renal transplantation Transplantation 41 5 1986 616 619
191. G. Vita, R. Dattola, R. Calabro, L. Manna, C. Venuto, and A. Toscano Comparative analysis of autonomic and somatic dysfunction in chronic uraemia Eur Neurol 28 6 1988 335 340
192. G. Solders, A. Persson, and A. Gutierrez Autonomic dysfunction in non-diabetic terminal uraemia Acta Neurol Scand 71 4 1985 321 327
193. E.S. Burgess Cardiac vagal denervation in hemodialysis patients Nephron 30 3 1982 228 230
194. D.J. Warren, R.B. Naik, and C.J. Mathias Vagal function in patients with chronic renal failure Contrib Nephrol 41 1984 199 222
195. K.C. Siamopoulos, E.V. Tsianos, M. Dardamanis, and C. Berecos Esophageal dysfunction in chronic hemodialysis patients Nephron 55 4 1990 389 393
196. W.C. Winkelmayer, M. Eigner, O. Berger, W. Grisold, and C. Leithner Optic neuropathy in uremia: an interdisciplinary emergency Am J Kidney Dis 37 3 2001 23
197. M. Mitz, A.S. Prakash, J. Melvin, and W. Piering Motor nerve conduction indicators in uremic neuropathy Arch Phys Med Rehabil 61 1 1980 45 48
198. R. Charachon, V. Moreno-Ribes, and D. Cordonnier Deafness due to renal failure. Clinicopathological study Ann Otolaryngol Chir Cervicofac 95 3 1978 179 203
199. M. Mitz, M. Di Benedetto, G.E. Klingbeil, J.L. Melvin, and Piering W Neuropathy in end-stage renal disease secondary to primary renal disease and diabetes Arch Phys Med Rehabil 65 5 1984 235 238
200. S. Laaksonen, K. Metsarinne, L.M. Voipio-Pulkki, and B. Falck Neurophysiologic parameters and symptoms in chronic renal failure Muscle Nerve 25 6 2002 884 890
201. M.L. D'Amour, L.R. Dufresne, C. Morin, and D. Slaughter Sensory nerve conduction in chronic uremic patients during the first six months of hemodialysis Can J Neurol Sci 11 2 1984 269 271
202. S. Laaksonen, L. Voipio-Pulkki, M. Erkinjuntti, M. Asola, and B. Falck Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 248 1 2000 21 26
203. T. Ogura, A. Makinodan, T. Kubo, T. Hayashida, and Y. Hirasawa Electrophysiological course of uraemic neuropathy in haemodialysis patients Postgrad Med J 77 909 2001 451 454
204. N.R. Robles, L. Murga, S. Galvan, J.F. Esparrago, and E. Sanchez-Casado Hemodialysis with cuprophane or polysulfone: effects on uremic polyneuropathy Am J Kidney Dis 21 3 1993 282 287
205. C.F. Bolton Electrophysiologic changes in uremic neuropathy after successful renal transplantation Neurology 26 2 1976 152 161
206. R.M. Hupperts, K.M. Leunissen, J.P. van Hooff, and J. Lodder Recovery of uremic neuropathy after renal transplantation Clin Neurol Neurosurg 92 1 1990 87 89
207. D.J. Read, T.G. Feest, and R.H. Holman Vibration sensory threshold: a guide to adequacy of dialysis? Proc Eur Dial Transplant Assoc 19 1983 253 257
208. H. Okada, K. Moriwaki, Y. Kanno, S. Sugahara, H. Nakamoto, and M. Yoshizawa Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin Nephrol Dial Transplant 15 9 2000 1410 1413
209. S. Kuwabara, R. Nakazawa, N. Azuma, M. Suzuki, K. Miyajima, and T. Fukutake Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients Intern Med 38 6 1999 472 475
210. K. Hassan, W. Simri, I. Rubenchik, J. Manelis, B. Gross, and S.M. Shasha Effect of erythropoietin therapy on polyneuropathy in predialytic patients J Nephrol 16 1 2003 121 125
211. B. Mansouri, B. Adybeig, M. Rayegani, S. Yasami, and V. Behshad Uremic neuropathy and the analysis of electrophysiological changes Electromyogr Clin Neurophysiol 41 2 2001 107 115
212. A.A. Amato, R.J. Barohn, Z. Sahenk, P.J. Tuschka, and J.R. Mendell Polyneuropathy complicating bone marrow and solid organ transplantation Neurology 43 8 1993 1513 1518
213. J.M. Campistol Uremic myopathy Kidney Int 62 5 2002 1901 1913
214. G.E. Moore, D.B. Parsons, J. Stray-Gundersen, P.L. Painter, K.R. Brinker, and J.H. Mitchell Uremic myopathy limits aerobic capacity in hemodialysis patients Am J Kidney Dis 22 2 1993 267 287
215. W. Diesel, M. Emms, B.K. Knight, T.D. Noakes, C.R. Swaenepoel, and R. van Zyl Smit Morphologic features of the myopathy associated with chronic renal failure Am J Kidney Dis 22 5 1993 677 684
216. R.P. Lazaro, and H.S. Kirshner Proximal muscle weakness in uremia. Case reports and review of the literature Arch Neurol 37 9 1980 555 558
217. E. De Bisschop, S. Allein, P. Van der Niepen, D. Verbeel en, R. Luypaert, and M. Osteaux Effect of amino acid administration on uremic muscle metabolism: a 31P-spectroscopy study Kidney Int 51 4 1997 1182 1187
218. R. Montagnac, F. Shillinger, B. Billaud, and G. Monvoisin Myopathy in uremic patients Rev Rhum Mal Osteoartic 57 3 1990 201 205
219. D.A. Feinfeld, P. Kurian, J.T. Cheng, G. Dilimetin, M.R. Arriola, and L. Ward Effect of oral l-carnitine on serum myoglobin in hemodialysis patients Ren Fail 18 1 1996 91 96
220. C.L. Kunis, G.S. Markowitz, X. Liu-Jarin, P.E. Fisher, G.L. Frei, and V.D. D'Agati Painful myopathy and end-stage renal disease Am J Kidney Dis 37 5 2001 1098 1104
221. I.H. Fahal, G.M. Bell, J.M. Bone, and R.H. Edwards Physiological abnormalities of skeletal muscle in dialysis patients Nephrol Dial Transplant 12 1 1997 119 126